Curevac to report fourth quarter and full-year 2023 financial results and business update on april 24, 2024

TÜbingen, germany and boston, ma / accesswire / april 18, 2024 / curevac n.v. (nasdaq:cvac) ("curevac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), will report financial results, and provide business updates for the fourth quarter and full-year 2023 on wednesday, april 24, 2024.
CVAC Ratings Summary
CVAC Quant Ranking